glp-1 and dual glp-1/gip receptor agonists The mechanisms of incretin agonists. Glucagon-like Mechanisms of action and therapeutic
Description
Diabetes care, 39 ,
The weight loss achieved varies by medication: liraglutide typically produces 5-8% weight loss, semaglutide approximately 15%, and tirzepatide up to 21% of initial body weight
The emphasis shifts to open and transparent communication between individuals and their healthcare providers
PMID 3528148
But the expert consensus is now that semaglutide and other GLP-1 drugs do not increase the risk of pancreatitis, says Drucker
The current study cannot fully separate those possibilities
